These innovative treatments , including copyright , belong to a category of drugs called GLP-1 receptor agonists . Primarily developed for treating diabetes mellitus , they operate by encouraging the pancreas to secrete sufficient insulin and limiting increased glucose levels. Additionally , their potential to promote weight management has led to i